Tocilizumab induces remission in severe Adult-onset Still's disease with progressive interstitial lung disease.
Adult-onset Still's disease presenting with periorbital erythematous rash and progressive interstitial lung disease.
Abstract
Tocilizumab induced clinical and radiological remission in an 80-year-old man with Adult-onset Still's disease (AOSD) and rapidly progressive interstitial lung disease (ILD).